Works matching IS 0167594X AND DT 2016 AND VI 129 AND IP 3

Results: 24

A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium study.

Published in:

Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 443, doi. 10.1007/s11060-016-2189-7

By:

Salloum, Ralph;
Hummel, Trent;
Kumar, Shiva;
Dorris, Kathleen;
Li, Shaoyu;
Lin, Tong;
Daryani, Vinay;
Stewart, Clinton;
Miles, Lili;
Poussaint, Tina;
Stevenson, Charles;
Goldman, Stewart;
Dhall, Girish;
Packer, Roger;
Fisher, Paul;
Pollack, Ian;
Fouladi, Maryam;
Boyett, James;
Drissi, Rachid

Publication type:

Article

Pembrolizumab: first experience with recurrent primary central nervous system (CNS) tumors.

Published in:

Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 453, doi. 10.1007/s11060-016-2190-1

By:

Blumenthal, Deborah;
Yalon, Michal;
Vainer, Gilad;
Lossos, Alexander;
Yust, Shlomit;
Tzach, Lior;
Cagnano, Emanuela;
Limon, Dror;
Bokstein, Felix

Publication type:

Article

Does the choice of antiepileptic drug affect survival in glioblastoma patients?

Published in:

Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 461, doi. 10.1007/s11060-016-2191-0

By:

Knudsen-Baas, Kristin;
Engeland, Anders;
Gilhus, Nils;
Storstein, Anette;
Owe, Jone

Publication type:

Article

The incidence and significance of multicentric noncontrast-enhancing lesions distant from a histologically-proven glioblastoma.

Published in:

Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 471, doi. 10.1007/s11060-016-2193-y

By:

Lasocki, Arian;
Gaillard, Frank;
Tacey, Mark;
Drummond, Katharine;
Stuckey, Stephen

Publication type:

Article

Age alone is not a predictor for survival in glioblastoma.

Published in:

Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 479, doi. 10.1007/s11060-016-2194-x

By:

Gately, Lucy;
Collins, Anna;
Murphy, Michael;
Dowling, Anthony

Publication type:

Article

A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma.

Published in:

Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 487, doi. 10.1007/s11060-016-2195-9

By:

Weathers, Shiao-Pei;
Han, Xiaosi;
Liu, Diane;
Conrad, Charles;
Gilbert, Mark;
Loghin, Monica;
O'Brien, Barbara;
Penas-Prado, Marta;
Puduvalli, Vinay;
Tremont-Lukats, Ivo;
Colen, Rivka;
Yung, W.;
de Groot, John

Publication type:

Article

Rapid progression of intracranial melanoma metastases controlled with combined BRAF/MEK inhibition after discontinuation of therapy: a clinical challenge.

Published in:

Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 389, doi. 10.1007/s11060-016-2196-8

By:

Cagney, Daniel;
Alexander, Brian;
Hodi, F.;
Buchbinder, Elizabeth;
Ott, Patrick;
Aizer, Ayal

Publication type:

Article

SHP-1 promoter 2 methylation in cerebrospinal fluid for diagnosis of leptomeningeal epithelial-derived malignancy (carcinomatous meningitis).

Published in:

Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 395, doi. 10.1007/s11060-016-2199-5

By:

Vinayanuwattikun, Chanida;
Mingmalairak, Siyamol;
Jittapiromsak, Nutchawan;
Thaipisuttikul, Iyavut;
Sriuranpong, Virote;
Mutirangura, Apiwat;
Shuangshoti, Shanop

Publication type:

Article

The clinical significance of fascin expression in a newly diagnosed primary glioblastoma.

Published in:

Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 495, doi. 10.1007/s11060-016-2200-3

By:

Park, Ki-Su;
Lee, Hye;
Park, Seong-Hyun;
Park, Tae;
Hwang, Jeong-Hyun

Publication type:

Article

Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.

Published in:

Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 505, doi. 10.1007/s11060-016-2201-2

By:

Kawaguchi, Tomohiro;
Sonoda, Yukihiko;
Shibahara, Ichiyo;
Saito, Ryuta;
Kanamori, Masayuki;
Kumabe, Toshihiro;
Tominaga, Teiji

Publication type:

Article

Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study.

Published in:

Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 515, doi. 10.1007/s11060-016-2202-1

By:

Sabel, Magnus;
Fleischhack, Gudrun;
Tippelt, Stephan;
Gustafsson, Göran;
Doz, François;
Kortmann, Rolf;
Massimino, Maura;
Navajas, Aurora;
Hoff, Katja;
Rutkowski, Stefan;
Warmuth-Metz, Monika;
Clifford, Steven;
Pietsch, Torsten;
Pizer, Barry;
Lannering, Birgitta

Publication type:

Article

Coexistence of MLH3 germline variants in colon cancer patients belonging to families with Lynch syndrome-associated brain tumors.

Published in:

2016

By:

Duraturo, Francesca;
Liccardo, Raffaella;
Izzo, Paola

Publication type:

Letter

Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis.

Published in:

Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 525, doi. 10.1007/s11060-016-2204-z

By:

Holla, F.;
Postma, T.;
Blankenstein, M.;
Mierlo, T.;
Vos, M.;
Sizoo, E.;
Groot, M.;
Uitdehaag, B.;
Buter, J.;
Klein, M.;
Reijneveld, J.;
Heimans, J.

Publication type:

Article

Expression of p40 (∆Np63) protein in meningiomas, an unexpected finding: immunohistochemical study and evaluation of its possible prognostic role.

Published in:

Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 405, doi. 10.1007/s11060-016-2205-y

By:

Guadagno, Elia;
Caro, Marialaura;
Pignatiello, Sara;
Sciammarella, Concetta;
Solari, Domenico;
Cappabianca, Paolo;
Maiuri, Francesco;
Dones, Flavia

Publication type:

Article

Impact of tapering and discontinuation of bevacizumab in patients with progressive glioblastoma.

Published in:

Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 533, doi. 10.1007/s11060-016-2206-x

By:

Hertenstein, Anne;
Hielscher, Thomas;
Menn, Oliver;
Wiestler, Benedikt;
Winkler, Frank;
Platten, Michael;
Wick, Wolfgang;
Wick, Antje

Publication type:

Article

Utility of MRI versus tumor markers for post-treatment surveillance of marker-positive CNS germ cell tumors.

Published in:

Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 541, doi. 10.1007/s11060-016-2207-9

By:

Cheung, Victoria;
Segal, Devorah;
Gardner, Sharon;
Zagzag, David;
Wisoff, Jeffrey;
Allen, Jeffrey;
Karajannis, Matthias

Publication type:

Article

A cure is possible: a study of 10-year survivors of brain metastases.

Published in:

Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 545, doi. 10.1007/s11060-016-2208-8

By:

Kotecha, Rupesh;
Vogel, Sally;
Suh, John;
Barnett, Gene;
Murphy, Erin;
Reddy, Chandana;
Parsons, Michael;
Vogelbaum, Michael;
Angelov, Lilyana;
Mohammadi, Alireza;
Stevens, Glen;
Peereboom, David;
Ahluwalia, Manmeet;
Chao, Samuel

Publication type:

Article

Low expressions of ASS1 and OTC in glioblastoma suggest the potential clinical use of recombinant human arginase (rhArg).

Published in:

2016

By:

Choy, Chi;
Wong, Chi;
Loong, Herbert

Publication type:

Letter

Anaplastic astrocytoma: prognostic factors and survival in 4807 patients with emphasis on receipt and impact of adjuvant therapy.

Published in:

Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 557, doi. 10.1007/s11060-016-2210-1

By:

Shin, Jacob;
Diaz, Aidnag

Publication type:

Article

Application of brush cytology for FISH-based detection of 1p/19q codeletion in oligodendroglial tumors.

Published in:

Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 415, doi. 10.1007/s11060-016-2211-0

By:

Srebotnik-Kirbiš, Irena;
Limbäck-Stokin, Clara

Publication type:

Article

Utilization and impact of adjuvant therapy in anaplastic oligodendroglioma: an analysis on 1692 patients.

Published in:

Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 567, doi. 10.1007/s11060-016-2212-z

By:

Shin, Jacob;
Diaz, Aidnag

Publication type:

Article

Mir-449a, a potential diagnostic biomarker for WNT group of medulloblastoma.

Published in:

Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 423, doi. 10.1007/s11060-016-2213-y

By:

Li, Yongxiao;
Jiang, Tao;
Shao, Liwei;
Liu, Yan;
Zheng, Chen;
Zhong, Yanfeng;
Zhang, Jing;
Chang, Qing

Publication type:

Article

The effects of sequential treatments on hippocampal volumes in malignant glioma patients.

Published in:

Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 433, doi. 10.1007/s11060-016-2188-8

By:

Nolen, Shantell;
Lee, Brian;
Shantharam, Shruti;
Yu, Hon;
Su, Lydia;
Billimek, John;
Bota, Daniela

Publication type:

Article

Rapid progression of intracranial melanoma metastases controlled with combined BRAF/MEK inhibition after discontinuation of therapy: a clinical challenge.

Published in:

Journal of Neuro-Oncology, 2016, v. 129, n. 3, p. 389, doi. 10.1007/s11060-016-2196-8

By:

Cagney, Daniel;
Alexander, Brian;
Hodi, F.;
Buchbinder, Elizabeth;
Ott, Patrick;
Aizer, Ayal

Publication type:

Article